Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank17
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P17
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-1.54%
202314.31%
2022378.25%
20210.00%
20200.00%
2019-100.00%
20180.00%